Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.

Revenue
−0.28%
EPS
−154.6%
Free cash flow
+38.8%
Total debt
−89.4%

Quarter to September 2026, against a year earlier

18.89 0.33 −1.72%
Market cap
$21.8B
P/E
0.0×
Fwd P/E
82.6×
Dividend yield
2.54%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100

Viatris Inc. (VTRS) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Viatris Inc. (VTRS) trades at a EV/FCF of 16.3×. Over the past ten years it has ranged from 5.7× (March 2025) to 171× (July 2015); the current reading is higher than 41% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 14.3× 111.64%
FY2024 6.7× (38.65%)
FY2023 11.0× (11.21%)
FY2022 12.4× (19.30%)
FY2021 15.3× (78.12%)
FY2020 70.1× 323.96%
FY2019 16.5× (29.51%)
FY2018 23.5× (23.92%)
FY2017 30.8× 11.17%
FY2016 27.7× (0.24%)

Quarterly newest first

Period EV/FCF Change
Sep 2026 15.7× (4.36%)
Jun 2026 16.4× 0.08%
Mar 2026 16.4× 14.60%
Dec 2025 14.3× (12.87%)
43 more quarters

Against its own ten years

Low 5.7× High 171×
Ten-year median 19.8×
Current reading's percentile 45

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on VTRS